Long-term Comparison of Vault and Complications of Implantable Collamer Lens with and without a Central Hole for High Myopia Correction: 5 Years

Chen, Xun; Wang, Xuanqi; Xu, Yilin; Cheng, Mingrui; Han, Tian; Wang, Xiaoying; Zhou, Xingtao

doi:10.1080/02713683.2021.2012202

Cited by 30 publications

(23 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, in the V4 group, 3.84% lost >2 lines of CDVA because of cataract development (3/78, vault 100 mm, 120 mm, and 160 mm). 38 These findings corroborate that the new central flow design reduces the risk and degree of lens opacification by allowing sufficient aqueous humor circulation, tolerating a lower vaulting than the older ICL V4 model. Longer follow-up studies on ICL V4c report likewise reassuring results.…”

Section: Discussionsupporting

confidence: 72%

See 1 more Smart Citation

Posterior chamber toric implantable collamer lenses vs LASIK for myopia and astigmatism: systematic review

Goes

Delbeke

2022

J Cataract Refract Surg

View full text Add to dashboard Cite

show abstract

Section: Discussionsupporting

confidence: 72%

“…Reduction in endothelial cell density after ICL V4c implantation was 2.4% at 5 years, 2.6% at 7 years, and 3.6 ± 7.0% at 8 years postoperatively, without significant endothelial cell density loss (>20%) in all 3 articles. 37–39…”

Section: Discussionmentioning

confidence: 99%

Posterior chamber toric implantable collamer lenses vs LASIK for myopia and astigmatism: systematic review

Goes

Delbeke

2022

J Cataract Refract Surg

View full text Add to dashboard Cite

show abstract

“…The incidence ranged from 0.3% to 28%, with an average onset time of 3.4 ± 1.9 years after ICL implantation. ACS has a significant positive correlation with age and a significant negative correlation with anterior chamber depth (ACD) [ 95 , 100 , 116 , 136 , 145 , 165 , 177 – 179 ].…”

Section: Summary and Treatment Of Postoperative Complications Of Iclmentioning

confidence: 99%

Analysis of perioperative problems related to intraocular Implantable Collamer Lens (ICL) implantation

et al. 2022

View full text Add to dashboard Cite

Purpose To introduce a modified procedure of ICL implantation, to summarize the perioperative problems and their corresponding treatment after myopia correction with Implantable Collamer Lens (ICL), and to compare the difference of complications between the no-hole ICL and hole ICL. Methods We searched all articles on ICL-related perioperative problems and their corresponding treatment in Scopus, Embase, PubMed and Web of Science databases for the last 22 years. Results ICL implantation is safe, effective, stable and predictable in the correction of myopia, hyperopia and astigmatism, but can also cause a series of perioperative problems, including intraoperative and postoperative complications. Conclusion There are many kinds of complications related to ICL, but the common intraoperative and postoperative complications mainly include abnormality of arch height, abnormal position of ICL, loss of corneal endothelial cells and corneal decompensation, high intraocular pressure and secondary glaucoma, cataract and night vision symptoms. Compared with ICL without central pore, the incidence of complications such as loss of corneal endothelial cells and corneal decompensation, high intraocular pressure and secondary glaucoma and cataract was relatively lower in central hole ICL, while postoperative complications such as night vision symptoms were obvious.

show abstract

“…32 Studies evaluating hole-ICL models reported ECC loss ranging 0.1-2.8% within 1 year postoperatively, 32,36,38,39,71 while it ranged from 0.43% to 21.8% decline in the final visit for studies with a follow-up of at least 4 years. 40,[50][51][52]69,72,73 The number of corneal endothelial cells tended to deteriorate more rapidly during the first year after ICL implantation. 74 In the US-FDA trial, ECC loss ranged from 8.4% to 9.7% in the first 3 years postoperatively and stabilized thereafter.…”

Section: Corneal Endothelial Cell Lossmentioning

confidence: 99%

Intraocular Implantable Collamer Lens with a Central Hole Implantation: Safety, Efficacy, and Patient Outcomes

Wannapanich¹,

Kasetsuwan²,

Reinprayoon³

2023

OPTH

View full text Add to dashboard Cite

This review summarizes the available literature and provides updates on the efficacy, safety, and patient outcomes of phakic intraocular lens implantation using implantable collamer lens (ICL), with a focus on newer models with a central port (EVO/EVO+ Visian Implantable Collamer Lens, STAAR Surgical Inc.). All studies included in this review were identified from the PubMed database and were reviewed for relevancy of their topic. Data on hole-ICL implantation performed between October 2018 and October 2022 in 3399 eyes showed a weighted average efficacy index of 1.03 and a weighted average safety index of 1.19 within an average follow-up of 24.7 months. The incidence of complications such as elevated intraocular pressure, cataract, and corneal endothelial cell loss was low. Moreover, both quality of vision and quality of life improved after ICL implantation, confirming the benefits of this procedure. In conclusion, ICL implantation is a promising refractive surgery alternative to laser vision correction with excellent efficacy, safety, and patient outcomes.

show abstract

Long-term Comparison of Vault and Complications of Implantable Collamer Lens with and without a Central Hole for High Myopia Correction: 5 Years

Cited by 30 publications

References 23 publications

Posterior chamber toric implantable collamer lenses vs LASIK for myopia and astigmatism: systematic review

Posterior chamber toric implantable collamer lenses vs LASIK for myopia and astigmatism: systematic review

Analysis of perioperative problems related to intraocular Implantable Collamer Lens (ICL) implantation

Intraocular Implantable Collamer Lens with a Central Hole Implantation: Safety, Efficacy, and Patient Outcomes

Contact Info

Product

Resources

About